| Tina Valcarenghi, SLP | |
|
5236 Colodny Dr, Suite #205, Agoura Hills, CA 91301-2624 | |
| (818) 865-8135 | |
| Not Available |
| Full Name | Tina Valcarenghi |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5236 Colodny Dr, Agoura Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083813067 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP3949 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tina Valcarenghi, SLP 5236 Colodny Dr, Suite #205, Agoura Hills, CA 91301-2624 Ph: (818) 865-8135 | Tina Valcarenghi, SLP 5236 Colodny Dr, Suite #205, Agoura Hills, CA 91301-2624 Ph: (818) 865-8135 |
News Archive
Life Technologies has completed a multi-year license and supply agreement with Quest Diagnostics, the world's leading provider of diagnostic information services, that gives Quest rights to develop molecular tests on the Ion Torrent next-generation sequencing platform. Under the agreement, Quest may use the platform and related consumables to independently develop new tests for numerous areas of their business.
Neurocrine Biosciences, Inc. announced today that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for its Vesicular Monoamine Transporter 2 inhibitor, NBI-98854, in tardive dyskinesia.
Since the declaration of the COVID-19 pandemic, many countries have implemented restrictions on mobility and social interactions, including lockdowns. This has been associated with a reduction in the number of extremely preterm (EP) babies, according to one Danish study. A recent paper published on the preprint server medRxiv in October 2020 reveals that this may not be the case.
"Managing and Securing Mobile Healthcare Data and Devices," a commissioned technology adoption profile conducted by Forrester Consulting on behalf of Fiberlink Communications Corporation was released today with findings on the top needs of healthcare IT leaders. With 95% of healthcare enterprises relying on smartphones for work, this industry is one of the most mobile across all verticals.
Virginia Premier Health Plan and Envision Pharmaceutical Services, Inc., today announced a multi-year agreement that establishes Envision as the exclusive provider of pharmacy benefit management (PBM) services for Virginia Premier's 150,000 managed Medicaid members starting 7/1/2012. The agreement is based on the pillars of pass-through pricing, transparency and service that will allow Virginia Premier unprecedented plan access and customization while achieving lower net costs.
› Verified 2 days ago
Taryn Reitman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4258 Via Mira Monte, Agoura Hills, CA 91301 Phone: 818-309-3420 | |
Denise Zweig, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5627 Kanan Rd Ste 184, Agoura Hills, CA 91301 Phone: 805-262-7809 | |
Amy Simon-weiner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5520 Fairgrange Dr, Agoura Hills, CA 91301 Phone: 818-991-4314 | |
Siri Ilene Woods, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29120 Quail Run Dr, Agoura Hills, CA 91301 Phone: 818-631-8410 | |
Chris Byers, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5012 Chesebro Rd, Suite 101, Agoura Hills, CA 91301 Phone: 818-419-1123 | |
Vicki Claymon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6314 Kerryhill Ct, Agoura Hills, CA 91301 Phone: 818-268-7693 |